Castration-Refractory Prostate Cancer: New Therapies, New Questions

Castration-Refractory Prostate Cancer: New Therapies, New Questions

Resistance to androgen deprivation is an ominous milestone in the natural history of metastatic prostate cancer:this disease state, now referred to as castration-refractory prostate cancer (CRPC), is historically associated with a median survival of

(Visited 1 times, 1 visits today)
3
Like
Save

Comments

Comments are disabled for this post.